Dinas Dynasty Logo Ovarian Cancer Fund.png

Dina's Dynasty Ovarian Cancer Fund

Established in memory of Dina Bray, Christy's mom and Mark's mother-in-law. Dina was our biggest cheerleader and most tireless volunteer. Never asking for anything in return, Dina gave her time and energy working in each aspect of the business from packaging shipments to sprinkling pecans. She wanted nothing more than to help her family succeed. In her memory, we give a portion of the sale of every box of toffee to the Dina's Dynasty Ovarian Cancer Fund.

In May of 2017, Dina was diagnosed with ovarian cancer. Three weeks later, she passed away. Her diagnosis came as a shock since her symptoms masqueraded, as ovarian cancer almost always does, as "normal." Upset stomach, bloating, discomfort in the abdomen. Unfortunately, there is currently no reliable screening method to diagnose ovarian cancer and our goal is to change that, so that no one else has to lose their wife, mother, sister or daughter. Or in Mark's case, their adoring mother-in-law.

Dina was a long time supporter and volunteer at UNC Lineberger Comprehensive Cancer Center, and the fund in her name aims to support UNC Lineberger in developing a reliable screening method for ovarian cancer and providing outstanding care for ovarian cancer patients.

For more information about the fund, or to make a donation, please visit https://www.dinasdynasty.org/


Lineberger NEW PNG.png

UNC Lineberger Comprehensive Cancer Center

One of only 49 NCI-designated comprehensive cancer centers, UNC Lineberger Comprehensive Cancer Center brings together some of the most exceptional physicians and scientists in the country to investigate and improve the prevention, early detection and treatment of cancer. With research that spans the spectrum from the laboratory to the bedside to the community, UNC Lineberger faculty work to understand the causes of cancer at the genetic and environmental levels, to conduct groundbreaking laboratory research, and to translate findings into pioneering and innovative clinical trials. For more information, please visit www.unclineberger.org